MEZAVANT® (mesalamine)

This product is registered in numerous countries throughout the world. If information relevant to your country is not available on this page, please consult your local physician.

This product is licensed in the following countries:

Australia (local website)
Austria
Belgium
Canada (local website)
Cyprus
Denmark (local website)
France (local website)  
Finland
Germany (local website)
Greece
Korea
Luxembourg
Netherlands (local website)
Norway
Spain (local website)
Sweden

Our global reach

Our products are marketed in over 50 countries worldwide, and we now have offices in 29 countries. View our interactive map, and learn more
about our global reach.

Our locations